Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Aphria Inc. APHA

Aphria, which is headquartered in Ontario, produces and sells medicinal and recreational cannabis. The company operates through retail and wholesale channels in Canada and internationally. Aphria is a main distributor of medical cannabis to Germany and has operations in over 10 countries outside of Canada. However, it does not have exposure to the U.S. CBD or THC markets due to the constraints of federal prohibition. It has some U.S. exposure through the acquisition of SweetWater, a craft brewer


NDAQ:APHA - Post by User

Bullboard Posts
Comment by INVSTIGAT0Ron Oct 14, 2019 8:49am
166 Views
Post# 30227958

RE:RE:RE:Happy Thanksgiving

RE:RE:RE:Happy Thanksgiving
As much as I hate the bad news surrounding other companies, it just makes Aphria look like an even stronger choice. Companies like TRST and Hexo were smaller cap companies than Aphria and we're considered a threat to Aphrias market share are no longer a threat, Canopy is a fallen giant that is now within our ability to beat and there are another 100+ companies that will not be able to expand any further than they already have due to lack of funding. Aphria has been funded and expanded the exact right amount that it needed to and we don't have to worry about insolvency here anymore. We're now at a time in the market where the only way forward is through organic growth and profitability and it's clear as day that Aphria is in the best position for this, by far. Organigram is the only other Canadian LP that appears to be a safe bet and they have nowhere near the footprint that we do. Even though other failures may impact our share price, all I'm seeing is gaps in the market that Aphria will be able to fill.
Bullboard Posts